Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
a study on Diffuse Cutaneous Systemic Sclerosis
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- Arthur Kavanaugh
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSD
- Arthur Kavanaugh
Research Interests Innovative strategies for the treatment of patients with rheumatoid arthritis and other rheumatic diseases. Prognostic and predictive factors for outcomes in rheumatic diseases. Research program on innovative approaches to various immunologic diseases, particularly novel biologic therapies.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Corbus Pharmaceuticals Inc.
- ID
- NCT03398837
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated